GCM Grosvenor Inc Ordinary Shares - Class A GCMG 深 滬
已收盤 10-24 16:00:00 美东时间
11.71
+0.050
+0.43%
華盛通- 最 高11.7598
- 今 開11.69
- 成交量 59.17万股
- 最 低 11.685
- 昨 收 11.66
- 總市值 6.23亿
- 52周最高 14.15
- 市盈率 靜 341.40
- 換手率 0.00%
- 52周最低 10.47
- 委 比 16.28%
- 總股本 5322.03万
- 歷史最高 14.15
- 量 比 0.76
- 振 幅 0.64%
- 歷史最低 4.84
- 每 手 1
- 風險率 0.67%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Analysts’ Top Financial Picks: GCM Grosvenor (GCMG), F.N.B. (FNB)
There’s a lot to be optimistic about in the Financial sector as 2 analysts just...
10-20 18:30
GCM Grosvenor Increases Quarterly Dividend
GCM Grosvenor ( ($GCMG) ) has issued an announcement. On October 15, 2025, GCM ...
10-15 19:57
GCM Grosvenor Posts Investor Day Presentation and Announces Dividend Increase
GCM Grosvenor announced its Investor Day presentation available on its website, featuring details on its long-term strategy, business drivers, and financial outlook. The event, held virtually and in person (invitation-only), includes presentations by CEO Michael Sacks, President Jon Levin, and CFO Pamela Bentley, among others. The company also revealed a quarterly cash dividend increase from $0.11 to $0.12 per share, annualized to $0.48, starting...
10-15 11:40
美股大行评级 | 潜在涨幅334.0%！HC Wainwright & Co.上调Inventiva目标价至24美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Inventiva"买入"评级，目标价从20美元升至24美元；摩根大通：维持BioMarin Pharmaceutical"超配"评级，目标价从116美元升至119美元
10-10 11:36
Piper Sandler Maintains Overweight on GCM Grosvenor, Lowers Price Target to $14
Piper Sandler analyst Crispin Love maintains GCM Grosvenor (NASDAQ:GCMG) with a Overweight and lowers the price target from $15 to $14.
10-09 21:53
GCM Grosvenor to Host Investor Day on October 15, 2025
GCM Grosvenor将举办投资者日活动，于2025年10月15日在纽约召开，时间为上午8:00 ET。此次活动将由公司董事会主席兼首席执行官Michael Sacks、总裁Jon Levin和首席财务官Pamela Bentley等高级管理层出席，重点介绍公司的长期战略、业务驱动因素、投资计划及财务展望，并设有现场问答环节。活动将在线上和线下同步进行，线下参与需邀请函，线上可通过官网直播参与。更多信息请访问www.gcmgrosvenor.com/public-shareholders或联系investorrelations@gcmlp.com。
08-08 13:00
GCM Grosvenor declares $0.11 dividend
GCM Grosvenor (NASDAQ:GCMG) declares $0.11/share quarterly dividend, in line with previous. Forward yield 3.67% Payable Sept. 16; for shareholders of record Sept. 2; ex-div Sept. 2. See GCMG Dividend ...
08-07 22:10
GCM Grosvenor Q2 Adj. EPS $0.16 Beats $0.15 Estimate, Sales $119.657M Beat $117.300M Estimate
GCM Grosvenor (NASDAQ:GCMG) reported quarterly earnings of $0.16 per share which beat the analyst consensus estimate of $0.15 by 3.9 percent. This is a 6.67 percent increase over earnings of $0.15 per share from the same
08-07 20:04
Earnings Scheduled For August 7, 2025
Companies Reporting Before The Bell • GoHealth (NASDAQ:GOCO) is estimated to re...
08-07 16:33
GCM Grosvenor Reports Second Quarter 2025 Earnings Results, with Year-To-Date Fundraising Increasing 52% Year-Over-Year, Year-to-Date GAAP Net Income, Fee-Related Earnings and Adjusted Net Income Increasing 130%, 14% and 19%, Respectively, Year-Over-Year
GCM Grosvenor reported its Q2 2025 results and announced a $30 million expansion of its share repurchase authorization, bringing total authorization to $220 million. The company also approved a $0.11 per share dividend, payable on September 16, 2025. A conference call to discuss the results was held on August 7, 2025, accessible via webcast or dial-in. GCM Grosvenor manages approximately $86 billion in alternative assets and serves a global clien...
08-07 12:00
